In Asia, RUSSING MED has invested in 10% ownership of Asian American Medical Group (AAMG), an ASX listed company and one of Asia’s foremost inpatient/outpatient Liver Transplant and Treatment and Blood and Marrow Transplant Centers. With a seat on the Board of Directors, one of RUSSING’s objectives is to help AAMG, leveraging on its collaboration with UPMC (a top US Health Care provider), to expand into other medical services provision, most notably into establishment and operation of modern Radiotherapy Treatment Centers in selected Asian markets, together with RUSSING MED in the Russian Federation and going forward in China and Eastern Europe.
RUSSING MED and AAMG may consider and offer co-investment opportunities to other external investors for these initiatives.
Company’s website